| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 345.60B | 349.35B | 344.15B | 319.50B | 286.48B | 269.20B |
| Gross Profit | 54.29B | 54.29B | 52.48B | 40.04B | 38.91B | 38.05B |
| EBITDA | 36.18B | 35.94B | 37.06B | 24.81B | 23.69B | 24.10B |
| Net Income | 11.86B | 11.86B | 13.74B | 1.19B | 83.00M | 732.00M |
Balance Sheet | ||||||
| Total Assets | 333.44B | 333.53B | 357.49B | 328.45B | 342.75B | 343.14B |
| Cash, Cash Equivalents and Short-Term Investments | 103.87B | 97.91B | 102.25B | 75.79B | 74.56B | 78.75B |
| Total Debt | 150.28B | 160.31B | 170.99B | 178.86B | 188.09B | 196.57B |
| Total Liabilities | 223.78B | 222.65B | 234.91B | 241.50B | 254.55B | 266.92B |
| Stockholders Equity | 96.07B | 95.70B | 101.64B | 66.77B | 68.02B | 58.37B |
Cash Flow | ||||||
| Free Cash Flow | 28.44B | 29.24B | 31.13B | 19.75B | 770.00M | 7.80B |
| Operating Cash Flow | 37.89B | 38.02B | 41.51B | 29.62B | 12.00B | 15.41B |
| Investing Cash Flow | -9.36B | -6.88B | -5.24B | -9.17B | -6.84B | -6.66B |
| Financing Cash Flow | -16.83B | -33.92B | -13.79B | -20.68B | -13.03B | 12.82B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥37.64B | 5.85 | ― | 3.77% | 0.14% | 882.91% | |
74 Outperform | €46.30B | 8.14 | 8.65% | 2.89% | -10.13% | -15.17% | |
74 Outperform | ¥48.27B | 17.14 | 4.24% | 1.97% | 3.51% | -0.74% | |
72 Outperform | ¥45.05B | 11.47 | ― | 2.36% | -13.35% | -19.38% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
61 Neutral | ¥42.75B | 3.58 | ― | 1.05% | -1.12% | -24.58% | |
51 Neutral | ¥16.66B | -64.43 | ― | 3.18% | -7.01% | -108.77% |
Mitsuba Corporation has announced the conclusion of a syndicated term loan agreement to refinance existing borrowings, amounting to 36,388 million yen, with a repayment deadline set for March 31, 2031. The agreement includes financial covenants to maintain equity levels and avoid consecutive fiscal losses, with minimal impact expected on the company’s financial results for the fiscal year ending March 2026.
Mitsuba Corporation reported a decline in net sales by 4.5% for the three months ended June 30, 2025, compared to the same period last year. Despite the decrease in sales, the company experienced a slight increase in operating profit by 3.9% and ordinary profit by 11.0%. The financial forecast for the fiscal year ending March 31, 2026, indicates a further decline in net sales and profits, reflecting challenges in the market and potential impacts on stakeholders.